COMMUNIQUÉS West-GlobeNewswire

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery [...]
Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program
08/09/2026
Company Anticipates $7M-$8M FY’26 Adjusted Gross Profit (1) , vs. Prior Guidance $5M-$7M Company Anticipates Adjusted Net Operating Cash Flow ( 4 ) to Turn Positive in Q3’26 Company Anticipates Generating Positive Core [...]
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
08/09/2026
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (Nasdaq: EPRX) (TSX: EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping
08/09/2026
New York State Department of Health approval allows clinical use of optical genome mapping (OGM) based lab developed tests (LDTs) for patients with suspected genetic disease, reproductive disorders, and hematologic [...]
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
08/09/2026
CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE ) today announced that it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, [...]
Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers
08/09/2026
HydraGlow Pre-Extraction Peel helps prep skin for easier, more effective extractions and improved exfoliation. Hydralock HA Biocellulose Mask hydrates, soothes and replenishes the skin barrier for a smooth, supple [...]
Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
SOLANA BEACH, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”) , a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to [...]
Global Genes Partners with Citizen Health to Power RARE-X
08/09/2026
RARE-X continues as an independent research platform and expands its capabilities to support research through medical record data collection and medical management for families using Ari, Citizen Health’s AI teammate [...]
Applied Biologics Welcomes New CMS RAPID Pathway and Expanded CMS-FDA Coordination for Innovative Medical Technologies
08/09/2026
Company believes earlier alignment of regulatory and Medicare evidence expectations could provide a valuable model for future drug and biologic development SCOTTSDALE, Ariz., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Applied [...]
HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
08/09/2026
Agreement includes pre-payment commitments for product sales and distribution of the second-generation multi-cytokine-based HCW11-006 for use as a reagent Akron is a leading supplier of critical ancillary materials and [...]
Tria Federal Joins Appian Public Sector Partner Program to Power Federal Missions
08/09/2026
Partnership with Appian will help agencies deliver mission outcomes at scale, on time and under pressure ARLINGTON, Va., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Tria Federal (Tria) announced today that it has become an [...]
Vivos Therapeutics Announces Material Debt Reduction
08/09/2026
Company Continues to Make Significant Progress to Enhance Stockholders' Equity and Satisfy Nasdaq Listing Requirements LITTLETON, Colo., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the [...]
NeOnc' Phase 2 Data Could Put Cancer on the Ropes
08/09/2026
NeOnc Looking to Turn Phase 2 Win into FDA Action DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – For NeOnc Technologies Holdings (NASDAQ: NTHI) , the Phase 2a question has been answered. Now comes the [...]
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
08/09/2026
First-of-Its-Kind Integration Connects TrakStar and AdvancedMD, Delivering TMS Care Across Clinical, Operational, and Billing Workflows MALVERN, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), [...]
Bone Biologics Expands Trial Sites
08/09/2026
Addition of three sites strengthens expectation to complete enrollment by year-end 2026 BURLINGTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics” or the “ [...]
Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer
08/09/2026
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals , a targeted cardiometabolic therapeutics company, today announced the appointment of George Eldridge as Chief Financial Officer. Mr. Eldridge brings [...]
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
08/09/2026
BURLINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present [...]
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (“ Optimi ” or the “ Company ”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic [...]
Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1
08/09/2026
U.S. Food and Drug Administration accepted the New Drug Application with Priority Review for tinlarebant for the treatment of Stargardt disease type 1; Prescription Drug User Fee Act target action date of February 12, [...]

Pages